Cited by 379Gene expression and cancer classificationBreast Cancer Treatment StudiesMicroRNA in disease regulation

DNA Microarrays in Clinical Oncology

Ramaswamy, Sridhar, Golub, Todd R.·2002·Journal of Clinical Oncology

Abstract

ABSTRACT: Aberrant gene expression is critical for tumor initiation and progression. However, we lack a comprehensive understanding of all genes that are aberrantly expressed in human cancer. Recently, DNA microarrays have been used to obtain global views of human cancer gene expression and to identify genetic markers that might be important for diagnosis and therapy. We review clinical applications of these novel tools, discuss some important recent studies, identify promising avenues of research in this emerging field of study, and discuss the likely impact that expression profiling will have on clinical oncology.

Integrity signals

Registry

Crossref · 10.1200/jco.2002.20.7.1932

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ramaswamy, S., & Golub, T. R.
Affiliations
Harvard University (US)
Venue
Journal of Clinical Oncology
Published
2002-04-01
Volume
20
Issue
7
Pages
1932-1941
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2144894933
Cited by
379
References
2
Citations by year
2025: 1 · 2024: 2 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 1 · 2017: 3 · 2015: 6 · 2014: 6 · 2013: 10 · 2012: 10
FWCI
4.02
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Keywords
DNA microarrays, gene expression profiling, cancer gene expression, aberrant gene expression, tumor initiation and progression, genetic markers, cancer diagnosis, cancer therapy, clinical oncology
MeSH terms
Humans, Neoplasms, Gene Expression Regulation, Neoplastic, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review